1、 WANG R H, SENGUPTI K, LI C, et al. Impaired DNA damage response, genome instability,and tumorigenesis in SIRT1 mutant mice[J]. Cancer Cell, 2008, 14(4): 312-323. WANG R H, SENGUPTI K, LI C, et al. Impaired DNA damage response, genome instability,and tumorigenesis in SIRT1 mutant mice[J]. Cancer Cell, 2008, 14(4): 312-323.
2、 朱春英,郭淑琴,张云良,等. 乳腺癌合并2型糖尿病患者沉默信息调节因子1表达及其意义[J]. 肿瘤研究与临床,2011,23(9):600-606. 朱春英,郭淑琴,张云良,等. 乳腺癌合并2型糖尿病患者沉默信息调节因子1表达及其意义[J]. 肿瘤研究与临床,2011,23(9):600-606.
3、 LEE H, KIM K R, NOH S J, et al. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma[J]. Hum Pathol, 2011, 42(2): 204-213. LEE H, KIM K R, NOH S J, et al. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma[J]. Hum Pathol, 2011, 42(2): 204-213.
4、 DENG C X. SIRT1, is it a tumor promoter or tumorsuppressor?[J]. Biol Sci, 2009, 5(2): 147-152. DENG C X. SIRT1, is it a tumor promoter or tumorsuppressor?[J]. Biol Sci, 2009, 5(2): 147-152.
5、 FIRESTEIN R, BLANDERG, MICHAN S, et al. The SIRT1 deacetylase suppresses in testinal tum origenes is and colon cancer growth[J]. PLoS One, 2008, 3(4): 20-24. FIRESTEIN R, BLANDERG, MICHAN S, et al. The SIRT1 deacetylase suppresses in testinal tum origenes is and colon cancer growth[J]. PLoS One, 2008, 3(4): 20-24.
6、 FU M, LIU M, SAUVE A A, et al. Hormonal control of and rogen receptor fun ction th rough SIRT1[J]. Mol Cell Biol, 2006, 26(1): 22-35. FU M, LIU M, SAUVE A A, et al. Hormonal control of and rogen receptor fun ction th rough SIRT1[J]. Mol Cell Biol, 2006, 26(1): 22-35.
7、 GUARANI V, POTENTE M.SIRT1: a metabolic sensor that controls blood vessel growth[J]. Curr Opin Pharmacol, 2010, 10(2): 139-145. GUARANI V, POTENTE M.SIRT1: a metabolic sensor that controls blood vessel growth[J]. Curr Opin Pharmacol, 2010, 10(2): 139-145.
8、 MOK S C,CHAN W Y,WONG K K,et al. SPARC,an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells[J]. Oncogene,1996,12(9):1895-1901. MOK S C,CHAN W Y,WONG K K,et al. SPARC,an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells[J]. Oncogene,1996,12(9):1895-1901.
9、 刘晓梅,于国华,张居民,等. 乳腺癌组织SPARC和VEGF表达临床意义的探讨[J]. 中华肿瘤防治杂志,2012,19(14):1061-1065. 刘晓梅,于国华,张居民,等. 乳腺癌组织SPARC和VEGF表达临床意义的探讨[J]. 中华肿瘤防治杂志,2012,19(14):1061-1065.
10、 徐东旭,徐璐,李彦君,等. SPARC蛋白在乳腺癌组织中的表达及临床意义[J]. 中国医科大学学报,2014,43(6):493-498. 徐东旭,徐璐,李彦君,等. SPARC蛋白在乳腺癌组织中的表达及临床意义[J]. 中国医科大学学报,2014,43(6):493-498.
